TSH-secreting pituitary adenomas and bone

Area of Science:

• Endocrinology
• Oncology
• Metabolic Bone Disease

Background:

• TSH-secreting pituitary adenoma (TSHoma) is a rare functioning pituitary tumor with increasing incidence.
• Delayed diagnosis of TSHoma leads to chronic hyperthyroidism and potential skeletal damage.
• Existing research on bone health in TSHoma is limited, with anecdotal data on bone mineral density (BMD).

Purpose of the Study:

• To investigate the prevalence and characteristics of skeletal damage in patients with TSHoma.
• To evaluate bone mineral density (BMD) and vertebral fractures (VFs) in TSHoma patients.
• To assess the impact of hyperthyroidism and potential protective factors on bone health in TSHoma.

Main Methods:

• Review of existing literature and case reports on TSHoma and skeletal complications.
• Analysis of bone turnover markers (BTM), BMD, and morphometric evaluation of VFs.
• Comparison of fracture prevalence between TSHoma and nonfunctioning pituitary adenoma (NFPA) patients.

Main Results:

• Increased bone resorption observed in TSHoma patients compared to controls.
• A high prevalence of morphometric vertebral fractures (VFs) was found in TSHoma patients.
• Older age and higher free thyroxine (fT4) levels were associated with fractures; somatostatin receptor ligands showed a protective role.

Conclusions:

• Comprehensive osteometabolic evaluation, including BTM, BMD, and VF assessment, is recommended for all TSHoma patients at diagnosis and during follow-up.
• Early detection and management of skeletal complications are vital, especially in high-risk individuals.
• Further research is needed to fully elucidate the long-term skeletal consequences of TSHoma and optimize treatment strategies.